KEEP UP WITH THE LATEST IN INDUSTRY NEWS!
From news about new medicines, pharmacy business insights, and the pharmaceutical industry in general—this is your source!
Drug Topics articles
- <![CDATA[Specialty Pharmacists Reduce Treatment Interruptions in Inflammatory Bowel Disease | ASHP Midyear 2025]]> December 7, 2025
- <![CDATA[Bridging Barriers in Health Care Delivery to Push Pharmacy’s Path Forward]]> December 7, 2025
- <![CDATA[Pharmacists Help Address Maternal Mortality With Drug Management | ASHP Midyear 2025]]> December 7, 2025
- <![CDATA[Pharmacists Step Up in Treating Cardiometabolic Conditions]]> December 6, 2025
- <![CDATA[Diet and Insulin Management Technology Show Most Consistent Benefits for Type 1 Diabetes]]> December 5, 2025
- <![CDATA[ACIP Vote Eliminates Universal Recommendation for Newborn Hepatitis B Vaccine]]> December 5, 2025
- <![CDATA[Pharmacists Employ Strategies for the Management of Chronic Diseases]]> December 5, 2025
- <![CDATA[Proactive Warning Is Crucial in Preventing OTC Drug Abuse]]> December 5, 2025
- <![CDATA[Pharmacists Remain Health Care Focal Point as Vaccine Recommendations Change]]> December 5, 2025
- <![CDATA[How TrumpRx Is Bringing Unprecedented Change to the Drug Supply Chain]]> December 4, 2025
Pharmacy Times articles
- <![CDATA[Deeper MRD Responses Strengthen Shared Decision-Making as Daratumumab Use Expands Across Treatment Phases]]> December 7, 2025
- <![CDATA[Long Term BENEFIT Data Affirm Isa-VRd as Standard of Care in Transplant-Ineligible NDMM]]> December 7, 2025
- <![CDATA[Improving Outcomes in Diffuse B-Cell Lymphoma Requires Multidisciplinary Evolution]]> December 6, 2025
- <![CDATA[Daratumumab Boosts Depth and Durability of Response After ASCT, Offering Clear Guidance for Pharmacist Counseling]]> December 6, 2025
- <![CDATA[American Cancer Society Updates Cervical Cancer Screening Guidelines to Include Self-Collection for HPV Testing]]> December 5, 2025
- <![CDATA[Closing the Travel Vaccine Gap: How Pharmacists Can Protect Global Travelers]]> December 5, 2025
- <![CDATA[Key Data, Interviews at the 2025 ASH Annual Meeting and Exposition]]> December 5, 2025
- <![CDATA[Unit-Based Pharmacy: Advancing Practice for Tomorrow]]> December 5, 2025
- <![CDATA[Implementing Enfortumab Vedotin-ejfv Plus Pembrolizumab: Navigating Safety Data and the Pharmacist’s Role]]> December 5, 2025
- <![CDATA[ACIP Votes to End Universal Hepatitis B Vaccination Recommendation for Infants]]> December 5, 2025
Helping You Navigate the Returns Process!
Pedigree Statement
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with it’s clients…
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with its clients. This is to ensure that the reverse distribution portion of the supply chain that we service keeps its functionality and integrity for our customers and the public.
Several pedigree and distribution level issues have been raised in the industry. Discounted, indigent-pricing, short dated, bulk purchase, secondary distribution, or DSCSA non-compliant sales could affect the credit available for a product based on a manufacturers determination. We ask that you do not return these products for credit as they are not eligible in most cases. Flash Returns LLC may choose to dispose of these on the pharmacies behalf at no charge if the cost is low relative to the return. Most customers purchasing products from reputable wholesalers will not encounter these issues, however all pharmacies are asked to acknowledge our policy on pedigree and legitimacy of product here and by signing the PSA before a return is initiated.
Some manufacturers may require proof the price paid for a product and what wholesaler distributed the product. Issues causing triggering this could be: bulk or large quantities of single items or lots, or products purchased speculatively. In some cases we may request invoices from the customer to ensure Flash Returns or manufacturer policy is being met. If none are available or if the information isn’t accepted by the manufacturer it could cause the return to be non-returnable.
Flash Returns, LLC cannot guarantee or be liable for the value or credit for products that were purchased outside of manufacturer accepted distribution channels. This could include products: purchased from a wholesaler that is not an approved vendor, products not purchased directly from a particular manufacturer, purchased on a speculative basis, diverted or counterfeit products, foreign products, and any product purchased on a non-returnable basis, including short-dated product purchased at discounted pricing.
At any time, Flash Returns, LLC or a manufacturer may require invoices or pedigree information demonstrating proof of purchase. If product has been shipped by Flash Returns, LLC or the Customer to a manufacturer or their agent, Flash Returns, LLC cannot guarantee or facilitate the return of product to the Customer. Manufacturers reverse the right to destroy product they deem not credit worthy or suspect. Manufacturers agreeing to return product to customers will do so at the customers expense. Flash Returns, LLC shall not be responsible for reimbursing a Customer for such product.
If Customer is unable to have product returned within 21 days, product is subject to be destroyed without any payment or credit issued to Customer. In any dispute, failure by Customer to provide invoices for a product or pedigree if requested shall release Flash Returns, LLC from any and all liability of products involved in dispute including the full value of the product. More information on drug pedigrees is available on the FDA website at:
Pedigree Statement
P: 833.553.5274
E: SignUp@FlashReturns.com
